Overview
neuroClues® is a CE-marked class IIa medical device that records eye movements to generate objective, reproducible, and quantified data for neurological assessment. The platform enables clinicians to support disease diagnosis and monitoring, with acquisition taking approximately 10 minutes and covered under a reimbursement code. It is trusted by neurologists and leading hospitals across Europe.
Key people
In the news
- Subtle eye movement abnormalities can appear early in parkinsonian syndromes, yet they’re rarely measured objectively in routine practice. Audrey Bonnan, PhD & Julien Tesse are heading to Milan for the annual congress of the International Association of Parkinsonism and Related Disorders. This event brings together leading experts from around the world to share the latest advances in Parkinson’s disease and related movement disorders. We’re excited to be part of it. 😁 Feel free to come to booth #13 to discover how eye movement
- Cette année encore, neuroClues exposera au congrès annuel de la Société Francophone des Mouvements Anormaux (SOFMA) ! Chaque année, le congrès de la SOFMA réunit les experts français des troubles du mouvement. Pour nous, c’est un rendez-vous à ne pas manquer. 📍 Paris, à l'ICM 📅 18 au 19 novembre C'est l'occasion : 👉 d'échanger avec les leaders d’opinion français en troubles du mouvement, dont les retours guident notre travail depuis le début. 👉 de présenter nos derniers développements : de nouvelles avancées pour rendre
- World Stroke Day | 29 October Could recording eye movements provide additional insights into neurological function after a stroke ? 👀 Eye movements are controlled by a complex network involving several brain regions, including the brainstem, cerebellum and cerebral cortex. When stroke disrupts these pathways, characteristic eye movement abnormalities can emerge. 🔬 According to the 2025 European Stroke Organisation guideline on visual impairment in stroke, eye movement abnormalities are present in approximately 40% of stroke
- As we recently marked World Mental Health Day on October 10, it's important to remember that mental health challenges are often intertwined with neurological conditions. Take Parkinson’s disease. While most people associate Parkinson's with tremor and movement difficulties, its impact extends far beyond motor symptoms. Depression, anxiety, apathy, psychosis, cognitive impairment, sleep disturbances, and impulse-control disorders are common throughout the course of the disease. https://hubs.ly/Q04Cr4yr0). In some cases, these
- Running together for a cause that matters. This weekend, the Bordeaux neuroClues Runner's Team proudly participated in the "Challenge Ruban Rose" to support breast cancer awareness and screening. A huge congratulations to Céline Kayal, PhD, Audrey Bonnan, PhD, Joann Sidi Boulenouar and Philippe Domineaux for their commitment, energy, and team spirit. 👏 We are proud to see our colleagues turning their energy into action and supporting the fight against breast cancer. #BreastCancerAwareness #ChallengeRubanRose #NeuroClues
- Goodbye, Follow the Finger. 🧠 Every day, neurologists strive to detect, diagnose, and monitor diseases such as Parkinson’s and Alzheimer’s. 👀 What if part of the answer could be found... in our eye movements? 🎥 The interview with Dr Thibault Warlop perfectly illustrates why this approach is relevant. It highlights how objective eye-movement measurements can help clinicians better understand neurological disorders and support more informed clinical decisions. 👉 Link to video : https://lnkd.in/eHUrQnKk Thanks a lot to
- 𝐀 𝐍𝐞𝐰 𝐒𝐩𝐚𝐜𝐞, 𝐀 𝐍𝐞𝐰 𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝐢𝐧 𝐋𝐢𝐥𝐥𝐞! ✨ We’re excited to set up at Eurasanté in Lille, right at the heart of a vibrant healthcare and innovation ecosystem! 🚀 Being surrounded by fellow start-ups creates great opportunities to connect, share ideas and learn from one another. For neuroClues, this is also an important step towards strengthening our presence in northern France and staying closer to the clinical teams we work with. 𝐍𝐞𝐰 𝐬𝐩𝐚𝐜𝐞, 𝐟𝐫𝐞𝐬𝐡 𝐞𝐧𝐞𝐫𝐠𝐲, 𝐬𝐚𝐦𝐞 𝐦𝐢𝐬𝐬𝐢𝐨𝐧: helping
- neuroClues rejoint La French Care ! Nous sommes très heureux de rejoindre La French Care, une communauté qui rassemble celles et ceux qui font avancer la santé grâce à l’innovation, la recherche et l’entrepreneuriat. 🤝 🔬 Chez neuroClues, nous développons une technologie d’enregistrement et d’analyse des mouvements oculaires qui aide les professionnels de santé à détecter des anomalies oculomotrices subtiles, et ainsi de compléter leur évaluation clinique des troubles neurologiques avec des données objectives et quantitatives.
Something wrong or missing? Send an update. Fixed within 24 hours.